Clinical Trial Update: Atorvastatin in the Recipient's Kidney Graft From a Living Donor [Phase 3]

View source ↗

Summary

Phase 3 trial investigating atorvastatin in recipients of kidney grafts from living donors with renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Recipient Health
• Renal Insufficiency

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Renal Insufficiency | Phase 3 | Status: COMPLETED